ChemoCentryx Inc Banner Image

ChemoCentryx Inc

  • Ticker CCXI
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
ChemoCentryx Inc Logo Image
  • 51-200 Employees
  • Based in San Carlos, California
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered therapeutics to treat autoimmune diseases, inflammatory disorders, and cancer in the United States. Its drug candidates in clinical development include CCX140 that has completed a Phase II clinical trial for the treatment of patients with diabeticMore nephropathy, a form of kidney disease; CCX872, an orally administered inhibitor that is under Phase Ib clinical trial for pancreatic cancer; and CCX168, which has completed a Phase II clinical trial for the treatment of anti-neutrophil cytoplasmic anti-body associated renal vasculitis.
4.8 / 5.0 (171)

ChemoCentryx Inc reports have an aggregate usefulness score of 4.8 based on 171 reviews.

ChemoCentryx Inc

Most Recent Annual Report

ChemoCentryx Inc
MOST RECENT 2021 Annual Report and Form 10K

ChemoCentryx Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

ChemoCentryx Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!